A social post says semaglutide and tirzepatide affect appetite, fullness and blood sugar, not only weight. A general explainer from a health account.
Recap by typeshit. Post by @livevoxy on Instagram.
A Facebook post credits Novo Nordisk's GLP-1 drugs with strong results in obesity and type 2 diabetes, plus lower risk of other conditions.
Lilly's tirzepatide shot Zepbound now has FDA approval in a KwikPen format for weight management. Tap through for details on the new pen.
At the SIO congress in Palermo, specialists flagged short real-world adherence and no national reimbursement in Italy. Oral semaglutide and orforglipron are expected there in 2027.
Polish pharmacy platform GdziePoLek says, citing the manufacturer, that the first Oral Wegovy shipment should arrive soon. No exact launch date is set yet.
A basic primer on how GLP-1 works in the body and its role in diabetes and weight management treatment.
The writer credits semaglutide and tirzepatide with real results, but argues medicine risks treating an environmental problem with lifelong medication.
Loading…